Skip to main content
. 2020 Apr 27;21(9):3081. doi: 10.3390/ijms21093081

Figure 7.

Figure 7

Flow cytometry after Rigenera® treatment. Immunophenotyping analysis of ASCs at p0 from Rigenera® treatment. The presence of the ASC phenotype is confirmed. Cell markers CD45 (a), CD34 (b), CD44/CD90 (c), CD73/CD105 (d), CD73/CD29 (e), and SSEA3 (f).